Terug
46
63
52
Dagbereik
€ 13,40
€ 14,29
52-Weeksbereik
€ 10,80
€ 79,18
Volume
1.278.994
50D / 200D Gem.
€ 25,57
/
€ 49,00
Vorige Slotkoers
€ 13,82
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Technology sector mediaan (621 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 7,1 | 12,3 |
| P/B | 2,0 | 2,9 |
| ROE % | 32,6 | 8,9 |
| Net Margin % | 13,7 | 5,6 |
| Rev Growth 5Y % | 38,1 | 9,2 |
| D/E | 0,1 | 0,3 |
Koersdoel Analisten
Hold
€ 35,83
+158.3%
Low: € 18,00
High: € 70,00
Forward K/W
18,77
Forward WPA
€ 0,75
WPA Groei (sch.)
+0,0%
Omzet Sch.
683,41M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,50
€ 1,21 – € 1,87
|
971,45M | 1 |
| FY2029 |
€ 1,25
€ 1,01 – € 1,56
|
894,73M | 1 |
| FY2028 |
€ 1,96
€ 1,09 – € 2,96
|
943,93M | 3 |
No quarterly estimates available
Insider Trading Activity
14 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 23, 2025 |
Freyre Michelle
Director
|
other | 6.918 | — | — |
| May 23, 2025 |
Freyre Michelle
Director
|
sell | 1.730 | € 74,60 | € 129.058,00 |
| May 23, 2025 |
Whitehurst James M
Director
|
other | 6.918 | — | — |
| May 23, 2025 |
Whitehurst James M
Director
|
sell | 1.730 | € 74,60 | € 129.058,00 |
| May 22, 2025 |
Freyre Michelle
Director
|
grant | 2.410 | — | — |
| May 22, 2025 |
Whitehurst James M
Director
|
grant | 2.410 | — | — |
| May 22, 2025 |
Harford Barney
Director
|
grant | 2.410 | — | — |
| May 22, 2025 |
Friend Matthew
Director
|
grant | 2.410 | — | — |
| May 22, 2025 |
HOOPER MICHELE J
Director
|
grant | 2.410 | — | — |
| May 22, 2025 |
ISAACSON WALTER
Director
|
grant | 2.410 | — | — |
| May 22, 2025 |
PHILIP EDWARD M
Director
|
grant | 5.422 | — | — |
| May 22, 2025 |
BREWER ROSALIND G
Director
|
grant | 2.410 | — | — |
| May 22, 2025 |
Ward Laysha
Director
|
grant | 2.410 | — | — |
| May 22, 2025 |
SHAPIRO EDWARD
Director
|
grant | 2.410 | — | — |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 38,12% annually over 5 years — strong growth
ROE of 32,63% indicates high profitability
Debt/Equity of 0,10 — conservative balance sheet
Generating 83,65M in free cash flow
P/E of 7,13 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 12,96%
Groei
Revenue Growth (5Y)
38,12%
Revenue (1Y)25,16%
Earnings (1Y)9,12%
FCF Growth (3Y)1,10%
Kwaliteit
Return on Equity
32,63%
ROIC20,36%
Net Margin13,67%
Op. Margin14,67%
Veiligheid
Debt / Equity
0,10
Current Ratio5,24
Interest Coverage0,00
Waardering
P/E Ratio
7,13
Forward P/E18,77
P/B Ratio1,99
EV/EBITDA3,61
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 25,16% | Revenue Growth (3Y) | 26,18% |
| Earnings Growth (1Y) | 9,12% | Earnings Growth (3Y) | 37,55% |
| Revenue Growth (5Y) | 38,12% | Earnings Growth (5Y) | 67,95% |
| Profitability | |||
| Revenue (TTM) | 809,84M | Net Income (TTM) | 110,75M |
| ROE | 32,63% | ROA | 9,73% |
| Gross Margin | 72,69% | Operating Margin | 14,67% |
| Net Margin | 13,67% | Free Cash Flow (TTM) | 83,65M |
| ROIC | 20,36% | FCF Growth (3Y) | 1,10% |
| Safety | |||
| Debt / Equity | 0,10 | Current Ratio | 5,24 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 7,13 | Forward P/E | 18,77 |
| P/B Ratio | 1,99 | P/S Ratio | 0,97 |
| PEG Ratio | 2,16 | Forward PEG | N/A |
| EV/EBITDA | 3,61 | Fwd EV/EBITDA | 2,47 |
| Forward P/S | 1,16 | Fwd Earnings Yield | 5,33% |
| FCF Yield | 10,60% | ||
| Market Cap | 789,47M | Enterprise Value | 428,19M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 809,84M | 647,04M | 508,69M | 324,52M | 222,56M |
| Net Income | 110,75M | 101,49M | 58,53M | 21,73M | 13,92M |
| EPS (Diluted) | 1,80 | 1,66 | 1,00 | 0,11 | 0,08 |
| Gross Profit | 588,71M | 468,32M | 358,23M | 218,05M | 153,18M |
| Operating Income | 118,77M | 115,60M | 74,32M | 27,67M | 19,51M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,14B | 438,88M | 404,91M | 216,41M | 142,97M |
| Total Liabilities | 741,30M | 156,58M | 121,80M | 117,70M | 74,32M |
| Shareholders' Equity | 396,50M | 282,30M | 283,11M | 98,71M | 68,65M |
| Total Debt | 40,93M | 22,71M | 12,51M | 15,88M | 5,35M |
| Cash & Equivalents | 402,21M | 50,34M | 36,54M | 40,96M | 28,83M |
| Current Assets | 601,80M | 223,37M | 223,81M | 145,93M | 92,70M |
| Current Liabilities | 114,83M | 124,80M | 109,31M | 90,41M | 55,57M |
Strategiescores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
#211 of 618
#77 of 670
#43 of 203
Recente Activiteit
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt
Value Investing (Warren Buffett)
Mar 24, 2026